---
title: "DUALITYBIO-B plans to issue RMB shares for listing on the Shanghai Stock Exchange's Sci-Tech Innovation Board"
description: "DUALITYBIO-B plans to issue RMB shares on October 17, 2025, and list on the Shanghai Stock Exchange's Sci-Tech Innovation Board. The issuance will be subject to market conditions, approval from the bo"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/261599708.md"
published_at: "2025-10-17T10:16:02.000Z"
---

# DUALITYBIO-B plans to issue RMB shares for listing on the Shanghai Stock Exchange's Sci-Tech Innovation Board

> DUALITYBIO-B plans to issue RMB shares on October 17, 2025, and list on the Shanghai Stock Exchange's Sci-Tech Innovation Board. The issuance will be subject to market conditions, approval from the board of directors and the shareholders' meeting, as well as regulatory approval. Currently, the board has no other plans regarding the issuance of RMB shares and has not submitted any applications to regulatory authorities

According to the Zhitong Finance APP, DUALITYBIO-B (09606) announced that on October 17, 2025, the company's board of directors resolved to issue ordinary shares that will be listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board and traded in RMB. The proposed issuance of RMB shares is subject to and limited by (including) market conditions, further approval from the board of directors, approval from shareholders at the company's general meeting, and necessary regulatory approvals.

As of the date of this announcement, apart from the preliminary proposal for the issuance of RMB shares and information disclosed separately in this announcement, the board of directors has no other plans regarding the proposed issuance of RMB shares, nor has it made any applications to the relevant regulatory authorities regarding the proposed issuance of RMB shares

### Related Stocks

- [09606.HK - DUALITYBIO-B](https://longbridge.com/en/quote/09606.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| TYK Medicines Gets Regulatory Nod to List 4.6 Million Converted Shares on Hong Kong Bourse | TYK Medicines Gets Regulatory Nod to List 4.6 Million Converted Shares on Hong Kong Bourse | [Link](https://longbridge.com/en/news/275738444.md) |
| Retal Urban Development Signs SSA With Alfozan Holding For Ajdan Co Shares | Retal Urban Development Company SJSC :RETAL URBAN DEVELOPMENT - SIGNS SHARE SWAP AGREEMENT WITH ALFOZAN HOLDING FOR AJDA | [Link](https://longbridge.com/en/news/275995528.md) |
| APT Electronics to Convert Over 21.7 Million Domestic Shares to Hong Kong-Listed Shares | APT Electronics to Convert Over 21.7 Million Domestic Shares to Hong Kong-Listed Shares | [Link](https://longbridge.com/en/news/275450557.md) |
| Contel Technology Announces Charge Of Shares Of The Controlling Shareholder | Contel Technology Co Ltd :CEO LAM KEUNG CHARGES SHARES OF P.GRAND IN FAVOUR OF CHARGEE AS SECURITY FOR A LOAN FACILITYP. | [Link](https://longbridge.com/en/news/275835556.md) |
| We Don’t Predict. We Position: How Jon Turned $4K of Risk Into a $30K Return | We Don’t Predict. We Position: How Jon Turned $4K of Risk Into a $30K Return | [Link](https://longbridge.com/en/news/276067278.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.